Fosfomycin for multidrug treatment of Klebsiella pneumoniae carbapenemase bacteremia

Ann Pharmacother. 2015 Mar;49(3):366-7. doi: 10.1177/1060028014564395.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteremia / drug therapy*
  • Bacterial Proteins / genetics
  • Drug Resistance, Multiple, Bacterial / drug effects*
  • Drug Resistance, Multiple, Bacterial / genetics
  • Drug Therapy, Combination
  • Fosfomycin / therapeutic use*
  • Humans
  • Klebsiella Infections / blood
  • Klebsiella Infections / drug therapy*
  • Klebsiella pneumoniae* / enzymology
  • Klebsiella pneumoniae* / genetics
  • Male
  • beta-Lactamases / genetics

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Fosfomycin
  • beta-Lactamases
  • carbapenemase